Cell and Gene

Plurify develop innovative solutions for efficiently differentiating PSCs to highly pure populations of transplantable cells. This approach will generate numerous therapeutics at scale and revolutionise cell therapies for many diseases with high unmet need.

Be part of SBC Catalyser Programme!

Spaces are limited to 10 companies per cohort. Contact Marco to get more information on our next programme in spring 2024.

Contact Marco

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.